Anagenics Limited has released a press release.
Key Antibody Patent Granted in Europe
Filed with ASX ·
6ix hasn’t read this filing yet.
Later from Anagenics
- Cellmid receives $1.12M R&D Tax Credit
- Cellmid to Refinance RnD Loan
- Response to ASX Query
- Midkine Strategy Update
- MK antibody publication and patent in bone healing
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics